The Global COVID-19 Index (GCI) - United States Dashboard

The GCI Dashboard

Version:

Country Rank

148

United States

Recovery Rank for 180 countries/regions

Country Rank

75

United States

Recovery Rank for 184 countries/regions

COVID-19 Recovery Rating

2

Recovery Index
45.81
(Out of 100)

(100 = Best, 0 = Worst)

COVID-19 Recovery Rating

3

Recovery Index
54.68
(Out of 100)

(100 = Best, 0 = Worst)

COVID-19 Severity Rating

4

Severity Index
68.35
(Out of 100)

(0 = Best, 100 = Worst)

COVID-19 Severity Rating

2

Severity Index
42.89
(Out of 100)

(0 = Best, 100 = Worst)

Stringency Rating

17.39

(100 = Strictest Measures, 0 = No Measures)

Population

328,239,523

(Medium Density)

GNI per capita (US$)

63,170

(High income)

COVID-19 Recovery Rating Guide

5	Countries who have made the most progress in curtailing the spread of the pandemic and can be used as examples of best practices (Relative Rating)
4
3
2	Countries who are struggling to cope with the crisis and who may need to consider maintaining stringent non-pharmaceutical measures (Relative Rating)
1

COVID-19 Severity Rating Guide

1	Countries who are coping with the crisis with a low percentage of infections and resulting deaths per population (Relative Rating)
2
3	Countries who may be overwhelmed by the crisis with a high percentage of infections and resulting deaths per population (Relative Rating)
4
5

Travel Advisory

United States - published 31.12.2021

1. Passengers entering or transiting through the USA must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passenger details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are: - AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm and Sinovac. A combination of these vaccines is accepted if administered at least 17 days apart. More details can be found at www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html This does not apply to: - nationals of the USA - residents of the USA; - passengers younger than 18; - passengers with a letter issued by a doctor proving that the passenger is medically unable to receive the vaccine; - passengers with the following visas: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1 (as an employee of TECRO or TECO or the employee's immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-4, or NATO-6 (or seeking to enter as a nonimmigrant in one of those NATO classifications); - passengers with a letter of invitation or other official document, issued by the USA, by other government or by the United Nations, traveling on duty; - nationals of Afghanistan, Algeria, Angola, Armenia, Benin, Burkina Faso, Burundi, Cameroon, Central African Rep., Chad, Congo, Congo (Dem. Rep.), Cote d'Ivoire, Djibouti, Egypt, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, Iraq, Kenya, Kiribati, Liberia, Libya, Madagascar, Malawi, Mali, Mozambique, Myanmar, Namibia, Nicaragua, Niger, Nigeria, Papua New Guinea, Senegal, Sierra Leone, Solomon Isl., Somalia, South Sudan, Syria, Tanzania, Togo, Uganda, Vanuatu, Yemen and Zambia, with a visa issued by the USA, excluding B -1 and B -2 visas; - members of the U.S. Armed Forces, their spouses, and children younger than 18 years; - merchant seamen with one of the following visas: C, D, C1/D, B1, H or L. - More details can be found at Requirement for Proof of COVID-19 Vaccination for Air Passengers \| CDC 2. Passengers entering or transiting through the USA must have a negative COVID-19 test taken at most 1 day before departure from the first embarkation point. Tests accepted are: antigen, NAAT, RT-LAMP, RT-PCR or TMA. - This does not apply to: - passengers younger than 2 years; - passengers with a positive COVID-19 test taken at most 90 days before departure from the first embarkation point; and - a letter issued by a health authority stating that the passenger has been cleared for travel. 3. Passengers must complete an attestation form before departure. The form can be found at https://tinyurl.com/f39bu7dt - This does not apply to passengers younger than 2 years. 4. Passengers are subject to COVID-19 measures set by the state/territory of their final destination. More information can be found at www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html 5. DV visas issued in September 2020 that expired are accepted for entry. 6. Nationals of the U.S.A. are allowed to enter with an expired passport. -This does not apply to emergency passports which must be valid on arrival. 7. Passengers could be subject to self-isolation or self-quarantine. - This does not apply to: - passengers with a COVID-19 recovery certificate proving recovery in the past 90 days; - passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passenger details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are: - AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm and Sinovac. A combination of these vaccines is accepted if administered at least 17 days apart. More details can be found at www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)

1. Passengers entering or transiting through the USA must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14
days) before arrival. Passenger details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are: -
AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm and Sinovac. A combination of these
vaccines is accepted if administered at least 17 days apart. More details can be found at www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html This
does not apply to: - nationals of the USA - residents of the USA; - passengers younger than 18; - passengers with a letter issued by a doctor proving that the passenger is
medically unable to receive the vaccine; - passengers with the following visas: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1
(as an employee of TECRO or TECO or the employee's immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-4, or NATO-6 (or seeking to enter as a nonimmigrant in one of
those NATO classifications); - passengers with a letter of invitation or other official document, issued by the USA, by other government or by the United Nations, traveling on
duty; - nationals of Afghanistan, Algeria, Angola, Armenia, Benin, Burkina Faso, Burundi, Cameroon, Central African Rep., Chad, Congo, Congo (Dem. Rep.), Cote d'Ivoire, Djibouti,
Egypt, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, Iraq, Kenya, Kiribati, Liberia, Libya, Madagascar, Malawi, Mali, Mozambique, Myanmar, Namibia, Nicaragua,
Niger, Nigeria, Papua New Guinea, Senegal, Sierra Leone, Solomon Isl., Somalia, South Sudan, Syria, Tanzania, Togo, Uganda, Vanuatu, Yemen and Zambia, with a visa issued by the
USA, excluding B -1 and B -2 visas; - members of the U.S. Armed Forces, their spouses, and children younger than 18 years; - merchant seamen with one of the following visas: C, D,
C1/D, B1, H or L. - More details can be found at Requirement for Proof of COVID-19 Vaccination for Air Passengers | CDC

2. Passengers entering or transiting through the USA must have a negative COVID-19 test taken at most 1 day before departure from the first embarkation point. Tests accepted are:
antigen, NAAT, RT-LAMP, RT-PCR or TMA. - This does not apply to: - passengers younger than 2 years; - passengers with a positive COVID-19 test taken at most 90 days before
departure from the first embarkation point; and - a letter issued by a health authority stating that the passenger has been cleared for travel.

3. Passengers must complete an attestation form before departure. The form can be found at https://tinyurl.com/f39bu7dt - This does not apply to passengers younger than 2 years.

4. Passengers are subject to COVID-19 measures set by the state/territory of their final destination. More information can be found at
www.cdc.gov/publichealthgateway/healthdirectories/healthdepartments.html

5. DV visas issued in September 2020 that expired are accepted for entry.

6. Nationals of the U.S.A. are allowed to enter with an expired passport. -This does not apply to emergency passports which must be valid on arrival.

7. Passengers could be subject to self-isolation or self-quarantine. - This does not apply to: - passengers with a COVID-19 recovery certificate proving recovery in the past 90
days; - passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passenger details
(e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are: - AstraZeneca (SK Bioscience), AstraZeneca
(Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm and Sinovac. A combination of these vaccines is accepted if administered at
least 17 days apart. More details can be found at www.cdc.gov/coronavirus/2019-ncov/travelers/international-travel-during-covid19.html

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)

United States Infection Trend

How can you tell if a curve is really flattening?

The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.

Countries with Similar Characteristics

This table is generated by a GCI-developed tool to match countries based on their similar characteristics such as population, population density, income and climate.

Country	Recovery Index	Recovery Index	Population	Density	GNI per capita	Average Temperature since First Case (Celsius)	Match%
United States	54.68	45.81	328,239,523	Medium Density	High income	< 10 deg
China	71.80	80.12	1,397,715,000	Medium Density	Upper middle income	< 10 deg	75%
Ethiopia	54.57	56.51	112,078,730	Medium Density	Low income	26-30 deg	60%
Indonesia	68.18	71.83	270,625,568	Medium Density	Upper middle income	26-30 deg	60%
Mexico	39.11	50.59	127,575,529	Medium Density	Upper middle income	21-25 deg	60%
Nigeria	58.04	61.66	200,963,599	Medium Density	Lower middle income	26-30 deg	60%

GCI Recovery Forecast

The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.

Forecast Results:

Situation May Improve. The GCI Model indicates that the situation has a small probability of recovery, but there is insufficient evidence to suggest that the recovery trend will improve significantly in the near future.